CVE-2022-1554

CVE-2022-1554 is a high-severity vulnerability in Clinical-genomics Scout with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-22.

Key facts

Description

Path Traversal due to `send_file` call in GitHub repository clinical-genomics/scout prior to 4.52.

Frequently asked questions

What is CVE-2022-1554?
Path Traversal due to `send_file` call in GitHub repository clinical-genomics/scout prior to 4.52.
How severe is CVE-2022-1554?
CVE-2022-1554 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2022-1554 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (67th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-1554?
CVE-2022-1554 affects Clinical-genomics Scout. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-1554?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2022-1554 published?
CVE-2022-1554 was published on 2022-05-03 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Clinical-genomics Scout

All CVEs affecting Clinical-genomics Scout →

Other CWE-22 (Path Traversal) vulnerabilities

Browse all CWE-22 (Path Traversal) vulnerabilities →